Revolution Medicines, Inc. (RVMD) Form 8-K — Jun 22, 2026

$RVMDForm 8-KItems 5.02, 5.07Filed Jun 22, 2026, 8:00 AM ET0001193125-26-276718Original filing

Dr. Steve Kelsey, President of Research and Development, has announced his retirement effective January 4, 2027, following a transition to a senior advisor role starting July 1, 2026. The company intends to appoint Dr. Kelsey to its board of directors upon his retirement, pending board approval, to maintain continuity.

Key figures

Shares Outstanding: 212592561
Retirement Date: 2027-01-04
Transition Date: 2026-07-01
Votes For Borisy: 127181172
Votes For Auditor: 181309783
Votes For Goldsmith: 157681628
Votes Withheld Borisy: 33660532
Votes Withheld Goldsmith: 3160076

Price after filing

1 day: +2.2%7 days: +7.5%30 days: +10.5%

Close on the filing date to close N calendar days later (from $165.81). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.